X.TOX.TOTSX
Loading
EBITDA Over TimeContracting
Percentile Rank86
3Y CAGR+10.5%
5Y CAGR+26.1%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+10.5%/yr
vs +34.7%/yr prior
5Y CAGR
+26.1%/yr
Recent deceleration
Acceleration
-24.2pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.12B | -13.7% |
| 2024 | $2.46B | +3.2% |
| 2023 | $2.38B | +51.6% |
| 2022 | $1.57B | +138.6% |
| 2021 | $658.00M | -1.0% |
| 2020 | $664.60M | +46.4% |
| 2019 | $453.90M | -4.8% |
| 2018 | $476.70M | +27.9% |
| 2017 | $372.60M | +10.9% |
| 2016 | $335.90M | - |